Torrent Pharmaceuticals Limited Overview
Pro stress-test →Torrent Pharmaceuticals is an India-based pharmaceutical company engaged in research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations across India, the US, Brazil, Germany, and internationally. The company operates across multiple therapeutic areas including cardiovascular, anti-diabetic, anti-microbial, oncology, gastro-intestinal, pain management, and vitamins, minerals, and nutrients.
Strategic Profile
Pro stress-test →As one of India's leading pharmaceutical companies incorporated in 1959, Torrent is focused on producing high-quality, affordable medicines for a wide range of diseases. The company demonstrated strong financial momentum in 2024, with revenue reaching ₹115.16 billion (up 7.35% year-over-year) and earnings of ₹19.11 billion (up 15.39%).
Competitive Landscape
Pro stress-test →Torrent operates in India's highly fragmented pharmaceutical market competing against integrated players like Sun Pharma, Cipla, Lupin, and Dr. Reddy's Labs, as well as international companies. The company differentiates through therapeutic focus areas (cardiovascular, CNS, GI) and geographic reach across developed and emerging markets.
Industry Context
Torrent Pharmaceuticals Limited operates in Pharmaceuticals - Branded and Generic.
Key facts
Founded: 1959 · Headquarters: Ahmedabad, India · Revenue: ₹115.16B (2024) · Market cap: ₹154,000 Cr (~$18.5B)